Skip to main content

Piper Jaffray , Caroline Stewart, Jacques Essinger

Premium

Piper Jaffray said this week that Caroline Stewart has joined the firm as a vice president and senior health care research analyst covering biotechnology companies. Stewart will be located in Piper Jaffray's New York office.

Stewart joins the firm from Morgan Joseph & Co./IRG, where she served as a senior research analyst covering small- to mid-cap development-stage and early-product biotechnology companies. She has also previously been employed by Leerink Swann/Medacorp, Salomon Smith Barney, and Deutsche Banc Securities. Stewart received her MS in molecular and cell biology and chemistry from Brandeis University.


Trophos this week appointed Jacques Essinger as president of the company's supervisory board.

Essinger has previously served as CEO of Modex Technologies, now Isotis Orthobiology. He holds a MS in physics and a PhD in biomechanics form the Swiss Federal Institute of Technology.

Trophos is a Marseille, France-based drug-discovery firm that uses a phenotypic screening platform to develop preclinical and clinical drug candidates for neurogenerative diseases.

 

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.